Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Arcus Biosciences, Inc. (RCUS) had Return on Investments of -25.28% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$26.00M |
|
$-135.00M |
|
-- |
|
$26.00M |
|
$168.00M |
|
$-142.00M |
|
$7.00M |
|
$-135.00M |
|
$-135.00M |
|
$-135.00M |
|
$-135.00M |
|
$-135.00M |
|
$-135.00M |
|
$-142.00M |
|
$-143.00M |
|
106.50M |
|
106.50M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$857.00M |
|
$42.00M |
|
$117.00M |
|
$974.00M |
|
$235.00M |
|
$98.00M |
|
$303.00M |
|
$538.00M |
|
$436.00M |
|
$436.00M |
|
$436.00M |
|
107.10M |
|
| Cash Flow Statement Financials | |
$-362.00M |
|
$248.00M |
|
$202.00M |
|
$153.00M |
|
$241.00M |
|
$88.00M |
|
$45.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.65 |
|
-- |
|
-- |
|
0.18 |
|
0.22 |
|
100.00% |
|
-546.15% |
|
-546.15% |
|
-- |
|
-519.23% |
|
-519.23% |
|
$-363.00M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
2.36 |
|
38.08 |
|
-30.96% |
|
-30.96% |
|
-13.86% |
|
|
Return on Investments |
-25.28% |
$4.07 |
|
$-3.41 |
|
$-3.40 |
|